GLP-1 Drugs May Add 7% Hair-Loss Risk in Baldness-Prone Men
A NYU Langone Mendelian randomization study links GLP1R gene activity to a 7 percent increase in male-pattern hair-loss risk among men already genetically susceptible to androgenetic alopecia.